115 related articles for article (PubMed ID: 3436681)
1. Re: Prophylaxis of gram-negative and gram-positive infections in rodents with three intravenous immunoglobulins and therapy of experimental polymicrobial burn wound sepsis with pseudomonas immunoglobulin and ciprofloxacin.
Stephan W; Dichtelmüller H
Infection; 1987; 15(6):463-4. PubMed ID: 3436681
[No Abstract] [Full Text] [Related]
2. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15(1):60-8. PubMed ID: 3570485
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
Tice AD; Marsh PK; Craven PC
Diagn Microbiol Infect Dis; 1990; 13(2):165-7. PubMed ID: 2196153
[No Abstract] [Full Text] [Related]
5. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin-loaded keratin hydrogels reduce infection and support healing in a porcine partial-thickness thermal burn.
Roy DC; Tomblyn S; Isaac KM; Kowalczewski CJ; Burmeister DM; Burnett LR; Christy RJ
Wound Repair Regen; 2016 Jul; 24(4):657-68. PubMed ID: 27238250
[TBL] [Abstract][Full Text] [Related]
8. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa.
Dale RM; Schnell G; Wong JP
Antimicrob Agents Chemother; 2004 Aug; 48(8):2918-23. PubMed ID: 15273101
[TBL] [Abstract][Full Text] [Related]
10. [Symposium "Ciflozin (ciprofloxacin)--a broad-spectrum antibacterial drug"].
Iakovlev VP
Antibiot Khimioter; 1992 Mar; 37(3):51. PubMed ID: 1514870
[No Abstract] [Full Text] [Related]
11. Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?
Heggers JP; Villarreal C; Edgar P; Wolf S; Klein GL; John SD; Desai M; Herndon DN
Arch Surg; 1998 Nov; 133(11):1247-50. PubMed ID: 9820358
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
[TBL] [Abstract][Full Text] [Related]
13. Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Al Omar S; Anabtawi N; Al Qasem W; Rihani R
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e131-e135. PubMed ID: 28234737
[TBL] [Abstract][Full Text] [Related]
14. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
Glik J; Kawecki M; Gaździk T; Nowak M
Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
[TBL] [Abstract][Full Text] [Related]
15. [Immunoglobulins and rules of passive-active prophylaxis].
Bucholc B
Przegl Epidemiol; 2003; 57(2):391-7. PubMed ID: 12910611
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants.
Stabile A; Miceli Sopo S; Romanelli V; Pastore M; Pesaresi MA
Arch Dis Child; 1988 Apr; 63(4):441-3. PubMed ID: 3284483
[TBL] [Abstract][Full Text] [Related]
17. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
[TBL] [Abstract][Full Text] [Related]
18. Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections.
Barekzi NA; Felts AG; Poelstra KA; Slunt JB; Grainger DW
Pharm Res; 2002 Dec; 19(12):1801-7. PubMed ID: 12523657
[TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
López A; Soler JA; Juliá A; Novo A; Bueno J
Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
[TBL] [Abstract][Full Text] [Related]
20. Oral ciprofloxacin in refractory gram-negative bacillary infections.
Bryant RE; Hartstein AI
Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
